EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • February 28th, 2019 • UroGen Pharma Ltd. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 28th, 2019 Company Industry JurisdictionThis Executive Employment Agreement (the “Agreement”), is hereby made this 3rd day of January, 2019, between UroGen Pharma, Inc., a wholly owned subsidiary (the “Subsidiary”) of UroGen Pharma, Ltd. (the “Parent”, and the Subsidiary and the Parent together, the “Company”), and Elizabeth Barrett (the “Executive”) (collectively, the “Parties”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • February 28th, 2019 • UroGen Pharma Ltd. • Pharmaceutical preparations • New York
Contract Type FiledFebruary 28th, 2019 Company Industry JurisdictionThis Executive Employment Agreement (the “Agreement”), is hereby made this 5th day of December, 2017, by and among UroGen Pharma, Inc., (the “Company”, a wholly-owned subsidiary of UroGen Pharma, Ltd., the “Parent”), the Parent, and Mark P. Schoenberg, MD (the “Executive”) (collectively, the “Parties”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • February 28th, 2019 • UroGen Pharma Ltd. • Pharmaceutical preparations • California
Contract Type FiledFebruary 28th, 2019 Company Industry JurisdictionThis Executive Employment Agreement (the “Agreement”), is hereby made this 17th day of January between UroGen Pharma, Inc., (the “Company”, a wholly-owned subsidiary of UroGen Pharma, Ltd., the "Parent") and Stephen L. Mullennix (the “Executive”, or “you”) (collectively, the “Parties”).
SEPARATION AND RELEASE AGREEMENTSeparation and Release Agreement • February 28th, 2019 • UroGen Pharma Ltd. • Pharmaceutical preparations • Nevada
Contract Type FiledFebruary 28th, 2019 Company Industry JurisdictionThis Separation and Release Agreement (the “Agreement”) is made and entered into by and between UroGen Pharma Ltd. (“Company”) of the first part and Gary S. Titus (“Titus”) of the second part.
SEPARATION AND RELEASE AGREEMENTSeparation and Release Agreement • February 28th, 2019 • UroGen Pharma Ltd. • Pharmaceutical preparations
Contract Type FiledFebruary 28th, 2019 Company IndustryThis Separation and Release Agreement (the “Agreement”) is made and entered into effective as of January 3, 2019 by and between UroGen Pharma Ltd. (“Company”) of the first part and Ron Bentsur (“Bentsur”) of the second part.